Silence Therapeutics Market Sentiment

Silence Therapeutics PLC

SLNNASDAQ

Trade with Public

$19.67

0.060.31%

最終更新: Oct 22, 8:47 AM

$19.65

0.03640.19%

概要ニュース業績予想イベント目標株価財務センチメント比較オプション株式レポート

M&A: Silence Therapeutics (SLN) announced it will be acquired by Merck KGaA on Monday, October 19, 2026 for $1.1B paid in cash

Silence Therapeutics Market Sentiment - Benzinga

Silence Therapeutics Market Sentiment

Market sentiment signals for Silence Therapeutics (SLN): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 5.0% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

7 analysts

Options Flow (P/C)

—

Avg Consensus PT

$32

+61.2%

Highest Price Target

$75

+281.7%

HC Wainwright & Co.

Lowest Price Target

-84.7%

Goldman Sachs

Short Interest

5.0%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 21, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+1.8%	$75 → $20	Downgrade	Buy→Neutral
Aug 11, 2026	Morgan Stanley	Michael Ulz—	+62.9%	$25 → $32	Maintained	Overweight
Jun 24, 2026	Cantor Fitzgerald	Prakhar Agrawal—	—	—	Initiate	Overweight
Jun 17, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+281.7%	$75 → $75	Maintained	Buy
Mar 13, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+281.7%	$75 → $75	Maintained	Buy
Sep 16, 2025	HC Wainwright & Co.	Patrick R. Trucchio—	+281.7%	$75 → $75	Maintained	Buy
Aug 8, 2025	Chardan Capital	Keay Nakae—	+78.1%	$35 → $35	Maintained	Buy
Jun 13, 2025	HC Wainwright & Co.	Patrick Trucchio—	+281.7%	$75 → $75	Maintained	Buy
Jun 13, 2025	Chardan Capital	Keay Nakae—	+78.1%	$35 → $35	Maintained	Buy
May 9, 2025	Goldman Sachs	Richard Law—	-84.7%	$4 → $3	Maintained	Sell
May 9, 2025	Morgan Stanley	Michael Ulz—	+27.2%	$45 → $25	Maintained	Overweight
May 9, 2025	Chardan Capital	Keay Nakae—	+78.1%	$55 → $35	Maintained	Buy
Mar 7, 2025	HC Wainwright & Co.	Patrick Trucchio—	+281.7%	$75 → $75	Maintained	Buy
Mar 5, 2025	Morgan Stanley	Michael Ulz—	+129.0%	$49 → $45	Maintained	Overweight
Mar 4, 2025	BMO Capital	Kostas Biliouris—	+27.2%	$67 → $25	Maintained	Outperform
Mar 4, 2025	Goldman Sachs	Richard Law—	-79.6%	$6 → $4	Maintained	Sell
Feb 11, 2025	Goldman Sachs	Richard Law—	-69.5%	$6	Initiate	Sell
Feb 3, 2025	HC Wainwright & Co.	Patrick Trucchio—	+281.7%	$75 → $75	Maintained	Buy
Jan 29, 2025	HC Wainwright & Co.	Patrick Trucchio—	+281.7%	$75 → $75	Maintained	Buy
Dec 10, 2024	Chardan Capital	Keay Nakae—	+179.9%	$55 → $55	Maintained	Buy
Dec 9, 2024	HC Wainwright & Co.	Patrick Trucchio—	+281.7%	$75 → $75	Maintained	Buy
Nov 20, 2024	HC Wainwright & Co.	Patrick Trucchio—	+281.7%	$75 → $75	Maintained	Buy
Nov 15, 2024	HC Wainwright & Co.	Patrick Trucchio—	+281.7%	$75 → $75	Maintained	Buy
Nov 14, 2024	Chardan Capital	Keay Nakae—	+179.9%	$55 → $55	Maintained	Buy
Oct 8, 2024	Morgan Stanley	Michael Ulz—	+149.4%	$49 → $49	Maintained	Overweight